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Summary Crimean—Congo hemorrhagic fever (CCHF) is an acute, tick-borne viral disease, with
the potential for human to human transmission. Infection often has severe hemorrhagic man-
ifestations and considerable mortality. Healthcare workers (HCWs) caring for patients with CCHF
constitute a major risk group for infection. Although nosocomial transmission from patients to
HCWs accounts for a significant proportion of CCHF cases and outbreaks worldwide, transmission
of CCHF from patient to patient has not previously been reported. A case of nosocomial
transmission of CCHF from patient to patient at a hospital is described.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
The CCHF virus is a tick-borne virus of the genus Nairovirus
within the family Bunyaviridae. These viruses are trans-
mitted by ticks of the Hyalomma genus, particularly by
Hyalomma marginatum marginatum. CCHF is an acute viral
disease with the potential for human to human transmission
that affects almost exclusively humans. Infection often
results in severe hemorrhagic manifestations, with a
reported mortality rate of 3—30%.1
The disease was first recognized as a clinical entity during
an investigation into an outbreak in Crimea in 1944—1945; it
was named Crimean hemorrhagic fever. Subsequently, the
causative agent was named Congo virus, after the agent
isolated from a human case in the Congo, and the name CCHF
virus was established.2 Virus isolation and infection have been
documented in more than 30 countries in Africa, Central and* Corresponding author. Tel.: +90 5325159984.
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Since 2002, the disease has been diagnosed throughout Turkey,
especially Central Anatolia and Black Sea regions.
The high risk of nosocomial outbreaks of CCHF was first
recognized in 1976, when a laparotomy was performed on a
CCHF patient in Pakistan with abdominal pain, hematemesis
and melena. Eleven secondary cases in hospital staff resulted
in three deaths, including the death of a surgeon and an
operating-theatre attendant. Since then, similar nosocomial
outbreaks have been reported in many countries.4 However,
nosocomial infection from patient to patient has not been
reported. Nosocomial infections usually have a more severe
prognosis. A case of nosocomial transmission of CCHF from
patient to patient is described.
Case report
In 2006, a 38-year-old female living in a rural area of Ankara
was admitted to hospital with high fever, dysuria and metror-
rhagia. She had been taking drugs for metrorrhagia for threePublished by Elsevier Ltd. All rights reserved.
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162  109/l, white blood cells 2.7  109/l, hemoglobin
5.3 g/dl, hematocrit 19%.
There was abundant pyuria in the patient’s urine. Urinary
tract infection caused by Klebsiella spp. was diagnosed and
appropriate antibiotic therapy was given. After three days of
hospitalization, there was no clinical improvement and pan-
cytopenia increased.We re-evaluated the patient and learned
from one of her relatives that, seven days before admission to
hospital, shehadbeenbittenbya tick,which shehad removed.
This patient was diagnosed with CCHF from IgM antibodies
detected by ELISA and from viral RNA detected by reverse
transcriptase (RT) PCR. The patient was isolated immediately.
A patient who had shared the same room as the index case
for five days had been in hospital for 25 days for treatment of
a brain abscess; she had never come into contact with a tick
and had never been to an endemic region. After contact with
the index case for five days in the same room, she developed
CCHF, with fever, chills, myalgia, arthralgia, headache,
abnormal liver function and hemorrhagic manifestations,
as confirmed by ELISA and PCR. IgM antibodies were detected
by ELISA at the Refik Saydam Hygiene Center of Ankara,
Turkey. A TaqMan-based one-step RT-PCR assay was used to
detect CCHF virus RNA.5 The assay was performed using a
Perkin—Elmer 7700 Sequence Detection System using a com-
bination of reverse transcriptase (MBI Fermentas, Vilnius,
Lithuania) and hot start Taq DNA polymerase (Brion GmBh,
Munchen, Germany) enzymes.
This second patient was regarded as having a nosocomial
infection. Neither patient was treated with ribavirin. They
recovered about two weeks after the onset of symptoms.
Discussion
The index case was the first patient in the CCHF outbreak of
2006 in Turkey. On admission, she did not mention any history
of tick bites. However, she had a urinary tract infection and
myoma of the uterus, which explained her symptoms.
CCHF is usually acquired by tick bite, contact with
infected animal blood or nosocomial transmission.6 Before
the index case was admitted to hospital, the second patient
had been in hospital for one month, including 5 days in the
Brain Surgery Clinic and 25 days in our clinic. Then, she
shared a room with the index case for five days. Because
of the short incubation period (usually 3—5 days) of the
infection following a tick bite or contact with blood, it
was impossible for her to be infected by any other way than
nosocomial transmission.
Hospital HCWs are at serious risk of transmission of CCHF
infection when caring for patients with hemorrhages from
the nose, mouth, gums, vagina and injection sites.6 CCHF
virus has repeatedly caused nosocomial outbreaks with a high
mortality rate. Percutaneous exposure presents the highest
risk of transmission.6,7
Nosocomial transmission of CCHF is well known and has
been described in outbreaks that have occurred in Dubai,
Pakistan, South Africa, Bulgaria and Turkey.7—13 In an out-
break that occurred in Dubai, five HCWs developed CCHF and
two died. One of the five secondary cases was an interpreter.
He had only been in the patient’s room and had not come into
contact with the patient. The four other secondary cases had
close contact with the patient.11It was reported that, in Pakistan, nosocomial CCHF trans-
mission occurred during a surgical intervention. One anesthe-
tist and two surgeons developed CCHF after operating on an
index case with gastrointestinal bleeding.9
In a South African outbreak, seven secondary cases
occurred, three of whom had never been in contact with
the index case; however, two had been in the patient’s room
and one had contact with medical waste. The rest of the
secondary cases had contact with the index case and three of
them were exposed to needle contact. Finally, one of the
secondary cases who had not come into contact with the
index case died.14 It can be assumed that the CCHF virus can
be transmitted by not only patient contact but also contact
with medical waste.7
Almost all of these nosocomial transmissions are from
patients to HCWs. There have not been any previously pub-
lished case reports on patient to patient nosocomial trans-
mission of CCHF. In this report, we describe patient to patient
nosocomial transmission of CCHF. We do not know for certain
how she became infected by the index case.
Based on experience in Africa, the transmission of viral
hemorrhagic fevers has been associated with the reuse of
non-sterile needles and syringes, and with the provision of
patient care without appropriate barrier precautions to pre-
vent exposure to virus-containing blood and other body fluids
(including vomit, urine and stool).15—17 There has been no
reuse of sterile or non-sterile needles and syringes in Turkey
for a long time. Because the history of tick bite was not
known, strict contact isolation measures, which must be
taken for CCHF patients, were not carried out when the
two patients were treated in the same room. Therefore,
while sharing the same room for five days, the secondary case
might have had some kind of contact with the index case’s
infected blood or body fluids. Indeed, as she had a urinary
infection and metrorrhagia, the index case frequently used
the toilet, which was also used by the secondary case. Using
the same toilet might have caused transmission of the virus
with blood and/or body fluids from patient to patient. In
addition, they might have shared personal items with
infected body fluids. The other remote possibility is airborne
transmission.15,16,18 Airborne transmission of CCHF infection
was suspected in several cases in Russia, but was not docu-
mented.19,1
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